PAR paradigm biopharmaceuticals limited..

research reports and media, page-4319

  1. 723 Posts.
    lightbulb Created with Sketch. 138

    I agree, Mozz. This was different. Other presentations or interviews felt quite homogenized with only a tiny snippet of new information.
    This was way more interesting, and Paul handled the challenges well, oozing confidence and control.

    The more open he is to the tough questions, the easier it will be for investors to trust in PAR's work.

    I'm getting the party hats dusted off, Mozz. I'm saving the silliest one for you.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.5¢
Change
0.005(1.85%)
Mkt cap ! $113.2M
Open High Low Value Volume
26.5¢ 28.5¢ 26.5¢ $189.6K 688.1K

Buyers (Bids)

No. Vol. Price($)
2 58644 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 3250 1
View Market Depth
Last trade - 16.10pm 16/09/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.